GHESKIO Wins 2010 Gates Award For Global Health
Main Category: HIV / AIDSArticle Date: 19 May 2010 - 1:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of groundbreaking clinical service, research and training to effectively treat and prevent the spread of the HIV/AIDS and other related illnesses.
GHESKIO -- it stands for Groupe Haïtien d'Étude du Sarcome de Kaposi et des Infections Opportunistes -- becomes the 10th winner of the annual Gates Award. Judges not only lauded the group for its impact from a long record of work but also for its life-saving and swift response to treat the sick and injured in the aftermath of the Jan. 12 earthquake that devastated Haiti. Despite sustaining substantial damage to its own facilities in Port-au-Prince, GHESKIO managed to open its doors to several thousand suddenly homeless people, and later opened a field hospital.
The group is led by Dr. Jean William Pape, professor of medicine at Weill Cornell Medical College. A Haitian native who has been one of the leading clinicians since the early days of the epidemic, Dr. Pape has been able to achieve AIDS patient survival rates and treatment adherence with patients that rival those of the most advanced hospitals and clinics in the United States and Europe. In addition, its research has informed the treatment and care of AIDS patients worldwide.
U.S. Secretary of Health and Human Services Kathleen Sebelius announced the award at a World Health Assembly symposium today. The Global Health Council has managed the award since its inception 10 years ago.
"No organization deserves this recognition more than GHESKIO. It has been a pioneer in developing comprehensive HIV/AIDS research, training and services in Haiti," says Sebelius. "And in the immediate aftermath of the January earthquake, GHESKIO responded by opening its doors, mobilizing its staff, and working side-by-side with U.S. medical and surgical teams to provide relief to the people of Port-au-Prince."
In thanking the committee and institutions for selecting GHESKIO, Dr. Pape cited the long-term commitment of people in the organization.
"For almost 30 years GHESKIO has tirelessly served those most in need in Haiti and translated its metric-based outcomes into effective policy for the prevention and treatment of HIV/AIDS and associated diseases such as tuberculosis into models for the developing world," says Dr. Pape.
He adds, "I could not be more proud of our Haitian staff who have worked diligently before, during and after the earthquake to meet the multiple needs of the population. They are the ones who, with our partners, have earned this recognition, which honors our country, Haiti."
"It has been 30 years since we began work in Haiti," says Dr. Warren Johnson Jr., director of the Center for Global Health at Weill Cornell, a co-founder of GHESKIO and Dr. Pape's adviser and mentor since Dr. Pape was a student in medical school at Weill Cornell. "It started with a rehydration unit for infants, progressed to treatment of AIDS and TB, and continues with the earthquake and its devastation. The challenges never diminish, but continue to be met by the indomitable spirit of GHESKIO and its partners. The award is a hard-earned honor."
GHESKIO will receive $1 million as part of the award, which was established by the Bill & Melinda Gates Foundation to recognize organizations that have made outstanding contributions to improving health, especially in resource-poor settings. The winner was chosen by a jury of international health leaders from 179 nominations received from around the world.
GHESKIO: From Earthquake Relief to HIV/AIDS Care
Just 24 hours after the earthquake, GHESKIO's downtown Port-au-Prince staff began establishing a first-response trauma center, which has since evolved into a major source of care for the injured. Roughly 7,000 Port-au-Prince residents, homeless because of the earthquake, moved onto GHESKIO's campus. Within a week of the earthquake, GHESKIO was able to ensure that 95 percent of those under care of HIV and tuberculosis were returned to their life-saving medications and care despite the destruction.
Prior to the earthquake, the GHESKIO network was providing palliative care to more than 50,000 HIV-infected patients and antiretroviral therapy to more than 13,500 -- roughly 55 percent of all patients on AIDS treatment in Haiti. In 2009, GHESKIO tested more than 500,000 patients for HIV, providing prevention counseling and treatment of sexually transmitted diseases for those who are negative, and treatment for those who are positive.
GHESKIO was created in 1982 after Haitian physicians from different specialties began observing a rise in mortality rates from previously treatable diseases such as diarrhea and Kaposi's sarcoma. In 1983, GHESKIO published the first description of HIV/AIDS in the developing world in the New England Journal of Medicine. Since its inception, GHESKIO has worked in close partnership with Weill Cornell Medical College, the Haitian Ministry of Health, the Haitian Medical Association and more than 100 public and private institutions in Haiti.
In 2000, the Haitian government designated GHESKIO a "public utility," a status usually reserved for institutions "essential to the welfare of the Haitian people," such as the Red Cross. In 2003, the Haitian government asked GHESKIO to expand its integrated prevention and care model to 26 public and private hospitals throughout the country. They provide training, supervision and administrative support at all of these sites, which include Haiti's four largest public hospitals.
The organization has been a major implementer of programs funded by the U.S. President's Emergency Plan for AIDS Relief and the Global Fund to Fight AIDS, TB and Malaria. It also has been a critical scientific partner in the HHS's AIDS Clinical Trials Group and the HIV Vaccine Trials Network.
Source
NewYork-Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Visit our hiv / aids section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/189142.php>
APA
http://www.medicalnewstoday.com/releases/189142.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




